JP2016132641A - Food taking method - Google Patents
Food taking method Download PDFInfo
- Publication number
- JP2016132641A JP2016132641A JP2015008329A JP2015008329A JP2016132641A JP 2016132641 A JP2016132641 A JP 2016132641A JP 2015008329 A JP2015008329 A JP 2015008329A JP 2015008329 A JP2015008329 A JP 2015008329A JP 2016132641 A JP2016132641 A JP 2016132641A
- Authority
- JP
- Japan
- Prior art keywords
- food
- hours
- sleep
- peak component
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229930188104 Alkylresorcinol Natural products 0.000 claims abstract description 22
- 241000209140 Triticum Species 0.000 claims abstract description 18
- 235000021307 Triticum Nutrition 0.000 claims abstract description 17
- 239000004480 active ingredient Substances 0.000 claims abstract description 16
- 238000004810 partition chromatography Methods 0.000 claims description 24
- 244000025254 Cannabis sativa Species 0.000 claims description 19
- 230000037406 food intake Effects 0.000 claims description 15
- 241000196324 Embryophyta Species 0.000 claims description 14
- 235000012631 food intake Nutrition 0.000 claims description 14
- 208000008589 Obesity Diseases 0.000 claims description 12
- 235000020824 obesity Nutrition 0.000 claims description 12
- 239000012675 alcoholic extract Substances 0.000 claims description 8
- 230000002618 waking effect Effects 0.000 claims description 8
- 230000002265 prevention Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 19
- 238000004587 chromatography analysis Methods 0.000 abstract description 7
- 239000000284 extract Substances 0.000 abstract description 7
- 241000209504 Poaceae Species 0.000 abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 125000004432 carbon atom Chemical group C* 0.000 description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 102000016267 Leptin Human genes 0.000 description 11
- 108010092277 Leptin Proteins 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 239000000469 ethanolic extract Substances 0.000 description 11
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 11
- 229940039781 leptin Drugs 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 210000001789 adipocyte Anatomy 0.000 description 9
- 230000003579 anti-obesity Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- -1 n-pentadecyl Chemical group 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- 208000001145 Metabolic Syndrome Diseases 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 102000011690 Adiponectin Human genes 0.000 description 4
- 108010076365 Adiponectin Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000000883 anti-obesity agent Substances 0.000 description 4
- 229940125710 antiobesity agent Drugs 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- OHTBGMREZYLZQD-UHFFFAOYSA-N 5-tricosylresorcinol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 OHTBGMREZYLZQD-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102000014777 Adipokines Human genes 0.000 description 3
- 108010078606 Adipokines Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 230000001969 hypertrophic effect Effects 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- PUNOCEUUYUXUGR-UHFFFAOYSA-N 5-Nonadecyl-1,3-benzenediol Chemical compound CCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 PUNOCEUUYUXUGR-UHFFFAOYSA-N 0.000 description 2
- GDJMJAKVVSGNLA-UHFFFAOYSA-N 5-Pentacosyl-1,3-benzenediol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 GDJMJAKVVSGNLA-UHFFFAOYSA-N 0.000 description 2
- BBGNINPPDHJETF-UHFFFAOYSA-N 5-heptadecylresorcinol Chemical compound CCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 BBGNINPPDHJETF-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 235000007264 Triticum durum Nutrition 0.000 description 2
- 241000209143 Triticum turgidum subsp. durum Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- KVVSCMOUFCNCGX-UHFFFAOYSA-N cardol Chemical compound CCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 KVVSCMOUFCNCGX-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000000229 preadipocyte Anatomy 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- BLHLKJLSYHEOGY-UHFFFAOYSA-N 5-Heneicosyl-1,3-benzenediol Chemical compound CCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 BLHLKJLSYHEOGY-UHFFFAOYSA-N 0.000 description 1
- LNHZINSBVLHRFL-UHFFFAOYSA-N 5-heptacosylbenzene-1,3-diol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 LNHZINSBVLHRFL-UHFFFAOYSA-N 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000218791 Ginkgoaceae Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 101001063890 Mus musculus Leptin Proteins 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Natural products OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000019647 acidic taste Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000478 adipokine Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 125000002460 pentacosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明は、イネ科植物種子由来の有用成分を含有する食品の摂取方法に関する。 The present invention relates to a method for ingesting foods containing useful ingredients derived from grass seeds.
近年、糖尿病、高血圧、動脈硬化等の症状が重複するメタボリックシンドロームと呼ばれる病態を持つ患者が増加している。メタボリックシンドロームには肥満が深く関わっていると考えられている。肥満は、過食によるエネルギーの過剰摂取や運動不足による消費エネルギー低下等により、脂肪細胞数の増加や脂肪細胞自身の肥大化が起こり、脂肪が過剰に蓄積した状態をいう。脂肪細胞は重量で人体の10%以上を占める巨大な組織であり、中性脂肪としてエネルギーを貯蔵するのみならず、アディポサイトカイン(脂肪組織由来生理活性物質)を分泌することにより、生体ホメオスタシスの維持に積極的に参与していると考えられている。脂肪を過剰に蓄積した肥大脂肪細胞からは各種のアディポサイトカインが分泌され、その結果、インスリン抵抗性、高血圧、高脂血症等が誘導される。肥満やメタボリックシンドロームを制御するためには、脂肪前駆細胞の肥大脂肪細胞への分化や脂肪蓄積の機構を解明し、それらを抑制することが重要である。 In recent years, an increasing number of patients have a pathological condition called metabolic syndrome in which symptoms such as diabetes, hypertension, and arteriosclerosis overlap. It is thought that obesity is deeply involved in the metabolic syndrome. Obesity refers to a state in which fat is excessively accumulated due to an increase in the number of fat cells or an enlargement of the fat cells due to excessive intake of energy due to overeating or a decrease in energy consumption due to lack of exercise. Adipose cells are a huge tissue that occupies more than 10% of the human body by weight. In addition to storing energy as neutral fat, adipocytokine (adipose tissue-derived physiologically active substance) is secreted to maintain biological homeostasis. It is believed that they are actively participating. Various adipocytokines are secreted from hypertrophic fat cells that have accumulated fat excessively, and as a result, insulin resistance, hypertension, hyperlipidemia, and the like are induced. In order to control obesity and metabolic syndrome, it is important to elucidate the mechanism of differentiation of fat precursor cells into hypertrophic adipocytes and the mechanism of fat accumulation and to suppress them.
特許文献1には、アディポサイトカインの一種であるアディポネクチンの分泌促進作用と脂肪前駆細胞の分化抑制作用及び脂肪細胞の脂肪蓄積抑制との関係、並びに、抗肥満関連遺伝子群の遺伝子発現変動及び血中アディポネクチンと中性脂肪との関係が示唆されており、アディポネクチンの分泌を誘導することが動脈硬化、肥満、糖尿病等の予防又は治療に有効であること、及び、特定の植物から抽出された特定成分がアディポネクチンの分泌を誘導することが開示されており、該特定成分として、レゾルシノール誘導体を含有するものが開示されている。
本発明者らは先に、抗肥満効果に優れ安全性の高い抗肥満剤として、イネ科植物種子のアルコール抽出物の分配クロマトグラフィーのピーク成分を有効成分として含有する抗肥満剤を提案した(特許文献2)。特許文献2記載の抗肥満剤によれば、脂肪前駆細胞の肥大脂肪細胞への分化、細胞内への脂肪蓄積が効果的に抑制される。特許文献2には、特許文献2記載の抗肥満剤の摂取時期について特段言及されていない。
The present inventors previously proposed an anti-obesity agent containing as an active ingredient a peak component of partition chromatography of an alcoholic extract of a grass plant seed as an anti-obesity agent having an excellent anti-obesity effect and high safety ( Patent Document 2). According to the anti-obesity agent described in
本発明の課題は、イネ科植物種子由来の有用成分を含む食品による作用効果を最大限に高め得る、食品の摂取方法に関する。 The subject of this invention is related with the food intake method which can heighten the effect by the foodstuff containing the useful ingredient derived from a Gramineae plant seed to the maximum.
本発明は、イネ科植物種子のアルコール抽出物の分配クロマトグラフィーのピーク成分を有効成分として含有する食品を、それを必要とする生体が睡眠から覚醒した後4時間以内に摂取させる、食品の摂取方法である。 The present invention relates to food intake, wherein a food containing a peak component of partition chromatography of an alcohol extract of a grass plant seed as an active ingredient is ingested within 4 hours after a living body that needs it wakes up from sleep. Is the method.
また本発明は、イネ科植物種子のアルコール抽出物の分配クロマトグラフィーのピーク成分を有効成分として含有する食品と、該食品についての説明書とを含み、該説明書に、該食品が肥満の予防若しくは改善に使用し得るか又は使用すべきであること、及び、睡眠から覚醒した後4時間以内に該食品を摂取することが記載されている商業用パッケージである。 The present invention also includes a food containing, as an active ingredient, a peak component of partition chromatography of an alcoholic extract of a grass seed and an instruction for the food, wherein the food is used to prevent obesity. Or a commercial package that describes or can be used for improvement and that the food is consumed within 4 hours after waking from sleep.
本発明の食品の摂取方法によれば、イネ科植物種子由来の有用成分を含む食品による作用効果が最大限に高められる。本発明で用いる食品には、脂肪細胞分化抑制作用及び脂肪蓄積抑制作用を有するものが含まれるところ、これらの作用効果が本発明の食品の摂取方法の実施によって最大限に高められるため、ヒトを含む哺乳動物の肥満の予防又は改善に繋がり得る。 According to the food intake method of the present invention, the action and effect of a food containing a useful ingredient derived from a grass family seed is maximized. The foods used in the present invention include those having an adipocyte differentiation inhibitory action and a fat accumulation inhibitory action, and these actions and effects are maximized by the implementation of the food intake method of the present invention. It can lead to the prevention or improvement of obesity in mammals including the same.
本発明で用いる食品は、イネ科植物種子のアルコール抽出物の分配クロマトグラフィーのピーク成分を有効成分として含有する、特定食品である。このピーク成分には、下記一般式(I)で表されるアルキルレゾルシノールの1種又は2種以上が含有されている。下記一般式(I)で表されるアルキルレゾルシノールは、脂肪細胞分化抑制作用及び脂肪蓄積抑制作用を有しており、これを含む特定食品には肥満の予防又は改善効果がある。本発明の食品の摂取方法は、過食症若しくは肥満症の予防若しくは改善、又は健康維持、美容を目的とする、いわゆる非医療目的で実施される方法を含む。 The food used in the present invention is a specific food containing, as an active ingredient, a peak component of partition chromatography of an alcohol extract of a grass plant seed. This peak component contains one or more alkylresorcinol represented by the following general formula (I). The alkylresorcinol represented by the following general formula (I) has an adipocyte differentiation inhibitory action and a fat accumulation inhibitory action, and a specific food containing the same has an effect of preventing or improving obesity. The food intake method of the present invention includes a method implemented for so-called non-medical purposes for the purpose of prevention or improvement of bulimia or obesity, health maintenance, and beauty.
前記一般式(I)におけるR1に関し、炭素原子数15〜25の飽和アルキル基としては、代表例として、n−ペンタデシル、n−ヘプタデシル、n−ノナデシル、n−ヘンイコシル、n−トリコシル、n−ペンタコシル、n−ヘプタコシル等の直鎖状のものが挙げられ、これらの他に、分岐状又は環状のものでも良い。これらの中でも、炭素原子数15〜23の飽和アルキル基が好ましい。 Regarding R 1 in the general formula (I), examples of the saturated alkyl group having 15 to 25 carbon atoms include n-pentadecyl, n-heptadecyl, n-nonadecyl, n-henicosyl, n-tricosyl, n- Examples include linear ones such as pentacosyl and n-heptacosyl, and besides these, branched or cyclic ones may be used. Among these, a saturated alkyl group having 15 to 23 carbon atoms is preferable.
また、前記一般式(I)におけるR1に関し、炭素原子数15〜25の不飽和アルキル基としては、前記の炭素原子数15〜25の飽和アルキル基に対応するものが挙げられる。不飽和アルキル基に含まれる不飽和結合の数及び位置に特に制限はない。 Moreover, regarding R 1 in the general formula (I), examples of the unsaturated alkyl group having 15 to 25 carbon atoms include those corresponding to the saturated alkyl group having 15 to 25 carbon atoms. There is no restriction | limiting in particular in the number and position of the unsaturated bond contained in an unsaturated alkyl group.
また、前記一般式(I)におけるR2は水素原子であることが好ましく、また、R1はR2に対してパラ位に結合していることが好ましい。 In the general formula (I), R 2 is preferably a hydrogen atom, and R 1 is preferably bonded to R 2 at the para position.
前記一般式(I)で表されるアルキルレゾルシノールの具体例としては、以下のものが挙げられる。
1,3−ジヒドロキシ−5−n−ペンタデシルベンゼン(C15:0)
1,3−ジヒドロキシ−5−n−ヘプタデシルベンゼン(C17:0)
1,3−ジヒドロキシ−5−n−ノナデシルベンゼン(C19:0)
1,3−ジヒドロキシ−5−n−ヘンイコシルベンゼン(C21:0)
1,3−ジヒドロキシ−5−n−トリコシルベンゼン(C23:0)
1,3−ジヒドロキシ−5−n−ペンタコシルベンゼン(C25:0)
Specific examples of the alkylresorcinol represented by the general formula (I) include the following.
1,3-dihydroxy-5-n-pentadecylbenzene (C15: 0)
1,3-dihydroxy-5-n-heptadecylbenzene (C17: 0)
1,3-dihydroxy-5-n-nonadecylbenzene (C19: 0)
1,3-dihydroxy-5-n-henicosylbenzene (C21: 0)
1,3-dihydroxy-5-n-tricosylbenzene (C23: 0)
1,3-dihydroxy-5-n-pentacosylbenzene (C25: 0)
本発明で用いる特定食品の好ましい一例として、下記6種類のアルキルレゾルシノールを含有するものが挙げられる。
1)前記一般式(I)におけるR1が炭素原子数15の飽和又は不飽和のアルキル基であるアルキルレゾルシノール(以下、AR15ともいう)。
2)前記一般式(I)におけるR1が炭素原子数17の飽和又は不飽和のアルキル基であるアルキルレゾルシノール(以下、AR17ともいう)。
3)前記一般式(I)におけるR1が炭素原子数19の飽和又は不飽和のアルキル基であるアルキルレゾルシノール(以下、AR19ともいう)。
4)前記一般式(I)におけるR1が炭素原子数21の飽和又は不飽和のアルキル基であるアルキルレゾルシノール(以下、AR21ともいう)。
5)前記一般式(I)におけるR1が炭素原子数23の飽和又は不飽和のアルキル基であるアルキルレゾルシノール(以下、AR23ともいう)。
6)前記一般式(I)におけるR1が炭素原子数25の飽和又は不飽和のアルキル基であるアルキルレゾルシノール(以下、AR25ともいう)。
As a preferred example of the specific food used in the present invention, one containing the following 6 types of alkylresorcinol can be mentioned.
1) Alkyl resorcinol (hereinafter, also referred to as AR15) in which R 1 in the general formula (I) is a saturated or unsaturated alkyl group having 15 carbon atoms.
2) Alkyl resorcinol (hereinafter, also referred to as AR17) in which R 1 in the general formula (I) is a saturated or unsaturated alkyl group having 17 carbon atoms.
3) Alkyl resorcinol (hereinafter, also referred to as AR19) in which R 1 in the general formula (I) is a saturated or unsaturated alkyl group having 19 carbon atoms.
4) Alkyl resorcinol (hereinafter, also referred to as AR21) in which R 1 in the general formula (I) is a saturated or unsaturated alkyl group having 21 carbon atoms.
5) Alkyl resorcinol (hereinafter, also referred to as AR23) in which R 1 in the general formula (I) is a saturated or unsaturated alkyl group having 23 carbon atoms.
6) Alkyl resorcinol (hereinafter, also referred to as AR25) in which R 1 in the general formula (I) is a saturated or unsaturated alkyl group having 25 carbon atoms.
AR15として特に好ましいものは、R1が炭素原子数15の飽和アルキル基、R2が水素原子であるものであり、具体的には、1,3−ジヒドロキシ−5−n−ペンタデシルベンゼン(C15:0)が挙げられる。
AR17として特に好ましいものは、R1が炭素原子数17の飽和アルキル基、R2が水素原子であるものであり、具体的には、1,3−ジヒドロキシ−5−n−ヘプタデシルベンゼン(C17:0)が挙げられる。
AR19として特に好ましいものは、R1が炭素原子数19の飽和アルキル基、R2が水素原子であるものであり、具体的には、1,3−ジヒドロキシ−5−n−ノナデシルベンゼン(C19:0)が挙げられる。
AR21として特に好ましいものは、R1が炭素原子数21の飽和アルキル基、R2が水素原子であるものであり、具体的には、1,3−ジヒドロキシ−5−n−ヘンイコシルベンゼン(C21:0)が挙げられる。
AR23として特に好ましいものは、R1が炭素原子数23の飽和アルキル基、R2が水素原子であるものであり、具体的には、1,3−ジヒドロキシ−5−n−トリコシルベンゼン(C23:0)が挙げられる。
AR25として特に好ましいものは、R1が炭素原子数25飽和アルキル基、R2が水素原子であるものであり、具体的には、1,3−ジヒドロキシ−5−n−ペンタコシルベンゼン(C25:0)が挙げられる。
Particularly preferred as AR15 is one in which R 1 is a saturated alkyl group having 15 carbon atoms and R 2 is a hydrogen atom. Specifically, 1,3-dihydroxy-5-n-pentadecylbenzene (C15 : 0).
Particularly preferred as AR17 is one in which R 1 is a saturated alkyl group having 17 carbon atoms and R 2 is a hydrogen atom. Specifically, 1,3-dihydroxy-5-n-heptadecylbenzene (C17 : 0).
Particularly preferred as AR19 is one in which R 1 is a saturated alkyl group having 19 carbon atoms and R 2 is a hydrogen atom. Specifically, 1,3-dihydroxy-5-n-nonadecylbenzene (C19 : 0).
Particularly preferred as AR21 is one in which R 1 is a saturated alkyl group having 21 carbon atoms and R 2 is a hydrogen atom. Specifically, 1,3-dihydroxy-5-n-henecosylbenzene ( C21: 0).
Particularly preferred as AR23 is one in which R 1 is a saturated alkyl group having 23 carbon atoms and R 2 is a hydrogen atom. Specifically, 1,3-dihydroxy-5-n-tricosylbenzene (C23 : 0).
Particularly preferred as AR25 is one in which R 1 is a C 25 saturated alkyl group and R 2 is a hydrogen atom. Specifically, 1,3-dihydroxy-5-n-pentacosylbenzene (C25 : 0).
本発明で用いる特定食品において、AR15、AR17、AR19、AR21、AR23及びAR25の含有量は、該特定食品による作用効果、特に抗肥満効果の一層の向上の観点から、それぞれ、下記範囲内にあることが好ましい。
AR15の含有量は、本発明で用いる特定食品中、好ましくは0.1〜10.0質量%、更に好ましくは0.1〜5.0質量%、特に好ましくは0.5〜1.5質量%である。
AR17の含有量は、本発明で用いる特定食品中、好ましくは1.0〜20.0質量%、更に好ましくは5.0〜15.0質量%、特に好ましくは8.0〜12.0質量%である。
AR19の含有量は、本発明で用いる特定食品中、好ましくは25.0〜40.0質量%、更に好ましくは27.5〜37.5質量%、特に好ましくは30.0〜35.0質量%である。
AR21の含有量は、本発明で用いる特定食品中、好ましくは40.0〜55.0質量%、更に好ましくは42.5〜52.5質量%、特に好ましくは45.0〜50.0質量%である。
AR23の含有量は、本発明で用いる特定食品中、好ましくは1.0〜15.0質量%、更に好ましくは2.5〜12.5質量%、特に好ましくは5.0〜10.0質量%である。
AR25の含有量は、本発明で用いる特定食品中、好ましくは0〜5.0質量%、更に好ましくは0〜2.0質量%、特に好ましくは0〜1.5質量%である。
In the specific food used in the present invention, the contents of AR15, AR17, AR19, AR21, AR23, and AR25 are within the following ranges, respectively, from the viewpoint of further improving the action effect of the specific food, particularly the anti-obesity effect. It is preferable.
The content of AR15 is preferably 0.1 to 10.0% by mass, more preferably 0.1 to 5.0% by mass, and particularly preferably 0.5 to 1.5% by mass in the specific food used in the present invention. %.
The content of AR17 is preferably 1.0 to 20.0% by mass, more preferably 5.0 to 15.0% by mass, and particularly preferably 8.0 to 12.0% by mass in the specific food used in the present invention. %.
The content of AR19 is preferably 25.0 to 40.0% by mass, more preferably 27.5 to 37.5% by mass, and particularly preferably 30.0 to 35.0% by mass in the specific food used in the present invention. %.
The content of AR21 is preferably 40.0 to 55.0% by mass, more preferably 42.5 to 52.5% by mass, and particularly preferably 45.0 to 50.0% by mass in the specific food used in the present invention. %.
The content of AR23 is preferably 1.0-15.0 mass%, more preferably 2.5-12.5 mass%, particularly preferably 5.0-10.0 mass% in the specific food used in the present invention. %.
The content of AR25 is preferably 0 to 5.0% by mass, more preferably 0 to 2.0% by mass, and particularly preferably 0 to 1.5% by mass in the specific food used in the present invention.
本発明で用いる特定食品は、AR15、AR17、AR19、AR21、AR23及びAR25以外の他のアルキルレゾルシノールの1種以上を含有していても良い。この他のアルキルレゾルシノールとしては、例えば、前記一般式(I)におけるR1が炭素原子数27の飽和又は不飽和のアルキル基であるアルキルレゾルシノール(以下、AR27ともいう)が挙げられる。AR27として特に好ましいものは、R1が炭素原子数27の飽和アルキル基、R2が水素原子であるものであり、具体的には、1,3−ジヒドロキシ−5−n−ヘプタコシルベンゼン(C27:0)が挙げられる。 The specific food used in the present invention may contain one or more alkylresorcinols other than AR15, AR17, AR19, AR21, AR23 and AR25. Examples of the other alkylresorcinol include alkylresorcinol (hereinafter, also referred to as AR27) in which R 1 in the general formula (I) is a saturated or unsaturated alkyl group having 27 carbon atoms. Particularly preferred as AR27 is one in which R 1 is a saturated alkyl group having 27 carbon atoms and R 2 is a hydrogen atom. Specifically, 1,3-dihydroxy-5-n-heptacosylbenzene ( C27: 0).
アルキルレゾルシノールは、天然の非イソテルぺノイド系フェノール性両親媒性化合物であるレゾルシノール脂質として、種々の植物に含まれていることが知られており、アルキルレゾルシノールの給源としては、イネ科植物以外にも、例えば、ウルシ科、イチョウ科、ヤマモガシ科、ヤブコウジ科、サクラソウ科、ニクズク科、アヤメ科、サトイモ科、キク科のヨモギ、マメ科等が知られている。これらの植物の中でも、イネ科植物は、可食性有効成分としてのアルキルレゾルシノールの研究が進んでいること等から、本発明においては、前記一般式(I)で表されるアルキルレゾルシノールの給源として、イネ科植物を採用している。 Alkylresorcinol is known to be contained in various plants as a resorcinol lipid, which is a natural non-isoterpenoid phenolic amphiphilic compound. In addition, for example, Urushiaceae, Ginkgoaceae, Porcupineaceae, Yabukodiidae, Primulaceae, Stigmaceae, Iridaceae, Araceae, Artemisia, Asteraceae, Legume, and the like are known. Among these plants, since gramineous plants have been studied for alkylresorcinol as an edible active ingredient, in the present invention, as a source of alkylresorcinol represented by the general formula (I), Employs gramineous plants.
前記一般式(I)で表されるアルキルレゾルシノールの給源として利用可能なイネ科植物としては、特に制限されないが、例えば、小麦、デュラム小麦、ライ麦、ライ小麦、大麦、オーツ麦、はと麦、トウモロコシ、イネ、ヒエ、アワ、キビ等の穀類が挙げられ、これら1種を単独で又は2種以上を組み合わせて用いることができる。これらの穀類の中でも、高い活性が得られる点から、特に小麦、デュラム小麦等のコムギ属の植物が好ましく、とりわけ小麦が好ましい。イネ科植物種子としては、任意の形態のイネ科植物種子で良く、例えば、イネ科植物種子(好ましくは種子外皮;糟糠類)そのもの;当該イネ科植物種子を切断、粉砕若しくは粉末化したもの;当該イネ科植物種子を乾燥したもの;当該イネ科植物種子を乾燥後粉砕若しくは粉末化したもの等でも良い。イネ科植物種子外皮を含む好適な例としては、ふすま、末粉、籾殻、ぬか等が挙げられる他、外皮を伴った種子も挙げられる。 The gramineous plant that can be used as a source of the alkylresorcinol represented by the general formula (I) is not particularly limited, and examples thereof include wheat, durum wheat, rye, rye wheat, barley, oats, and wheat. Examples include cereals such as corn, rice, millet, millet, millet, and the like can be used alone or in combination of two or more. Among these cereals, wheat plants such as wheat and durum wheat are particularly preferable from the viewpoint of obtaining high activity, and wheat is particularly preferable. The gramineous plant seed may be any form of gramineous plant seed, for example, gramineous plant seed (preferably seed hull; moss) itself; a product obtained by cutting, crushing or pulverizing the gramineous plant seed; It may be a product obtained by drying the grass plant seed; a product obtained by drying or crushing or powdering the grass seed. Preferable examples including grass seed hulls include bran, powder, rice husk, bran and the like, and seeds with hulls.
イネ科植物種子のアルコールによる抽出方法は特に制限されないが、例えば、前記各種形態のイネ科植物種子をアルコール中に浸漬、攪拌又は還流する方法の他、超臨界流体抽出法等が挙げられる。イネ科植物種子をアルコール中に浸漬、攪拌又は還流する方法の場合、抽出温度(アルコールの液温)は2〜100℃が好ましく、抽出時間は0.5〜72時間が好ましく、アルコール使用量は、イネ科植物種子100質量部に対し50〜2000質量部が好ましい。 The method for extracting grass seeds with alcohol is not particularly limited, and examples thereof include a supercritical fluid extraction method in addition to a method of immersing, stirring, or refluxing various kinds of grass seeds in alcohol. In the case of the method of immersing, stirring or refluxing grass seeds in alcohol, the extraction temperature (alcohol liquid temperature) is preferably 2 to 100 ° C., the extraction time is preferably 0.5 to 72 hours, and the amount of alcohol used is 50-2000 mass parts is preferable with respect to 100 mass parts of gramineous plant seeds.
イネ科植物種子の抽出に用いられるアルコールとしては、例えば、メタノール、エタノール、n−プロパノール、イソプロパノール、n−ブタノール等の1価の低級アルコール(好ましくは炭素原子数1〜4のもの)、及び1,3−ブチレングリコール、プロピレングリコール、グリセリン等の多価アルコール等の室温(25℃)で液体であるアルコールが挙げられる。これらのアルコールの中でも、操作性や環境性の点から、エタノールが好ましい。尚、イネ科植物種子の抽出に用いられるアルコールとしては、アルコール以外の水性成分(水、純水、蒸留水、水道水、酸性水、アルカリ水、中性水等)が含まれている含水エタノールを用いることもできる。含水アルコール中のアルコール含有量は、通常70体積%以上、好ましくは80体積%以上、より好ましくは90体積%以上である。 Examples of the alcohol used for the extraction of grass seeds include monovalent lower alcohols (preferably those having 1 to 4 carbon atoms) such as methanol, ethanol, n-propanol, isopropanol, and n-butanol, and 1 , 3-butylene glycol, propylene glycol, polyhydric alcohols such as glycerin, and the like, which are liquids at room temperature (25 ° C.). Among these alcohols, ethanol is preferable from the viewpoint of operability and environmental properties. In addition, as alcohol used for the extraction of gramineous plant seeds, water-containing ethanol containing aqueous components (water, pure water, distilled water, tap water, acidic water, alkaline water, neutral water, etc.) other than alcohol Can also be used. The alcohol content in the hydrous alcohol is usually 70% by volume or more, preferably 80% by volume or more, more preferably 90% by volume or more.
イネ科植物種子のアルコール抽出物は、分配クロマトグラフィーによって精製される。分配クロマトグラフィーは、本発明で用いる特定食品の有効成分、即ち前記一般式(I)で表されるアルキルレゾルシノールが得られる手法であればその種類は問わないが、移動相として非水系溶媒を用いる順相クロマトグラフィー法が好ましく、オープンカラム法、中圧カラム法、高速液体クロマトグラフィー等の公知の方法を適宜選択することができる。 The alcoholic extract of gramineous seeds is purified by partition chromatography. The partition chromatography may be of any type as long as it is a technique for obtaining the active ingredient of the specific food used in the present invention, that is, the alkylresorcinol represented by the general formula (I), but a nonaqueous solvent is used as the mobile phase. A normal phase chromatography method is preferable, and a known method such as an open column method, a medium pressure column method, or a high performance liquid chromatography can be appropriately selected.
イネ科植物種子のアルコール抽出物の分配クロマトグラフィーにおける移動相としては、メタノール、エタノール、n−プロパノール、イソプロパノール、n−ブタノール等の1価の低級アルコール(好ましくは炭素原子数1〜4のもの)、及び1,3−ブチレングリコール、プロピレングリコール、グリセリン等の多価アルコール等の室温(25℃)で液体であるアルコール;ジエチルエーテル、プロピルエーテル等のエーテル;酢酸ブチル、酢酸エチル等のエステル;アセトン、エチルメチルケトン等のケトン;ヘキサン;塩化メチレン;アセトニトリル;並びにクロロホルム等が挙げられ、これら溶媒の1種を単独で又は2種以上を組み合わせて用いることができる。複数の溶媒を組み合わせて移動相とする場合、分配クロマトグラフィーの実施中(イネ科植物のアルコール抽出物の精製中)において、複数の溶媒の混合比を一定にするイソクラクティックモードでも良く、あるいは該混合比を変化させるグラジエントモードでも良い。また、分配クロマトグラフィーにおける担体としては、目的とする有効成分を担持−放出できる担体であればいずれも用いることができるが、一般的にはシリカゲル、ポリアクリルアミドゲル、デキストランゲル等を挙げることができる。イネ科植物種子のアルコール抽出物の分配クロマトグラフィーにおける検出波長は、170〜320nmであれば良く、好ましくは190〜280nmである。 As the mobile phase in the partition chromatography of the alcoholic extract of the grass seed, monovalent lower alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol (preferably having 1 to 4 carbon atoms) And alcohols that are liquid at room temperature (25 ° C.) such as polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, and glycerin; ethers such as diethyl ether and propyl ether; esters such as butyl acetate and ethyl acetate; acetone And ketones such as ethyl methyl ketone; hexane; methylene chloride; acetonitrile; and chloroform. These solvents can be used alone or in combination of two or more. When a plurality of solvents are combined to form a mobile phase, an isocratic mode in which the mixing ratio of the plurality of solvents is kept constant during partition chromatography (purification of the gramineous alcohol extract), or A gradient mode in which the mixing ratio is changed may be used. Any carrier can be used as the carrier in the partition chromatography as long as it can carry and release the target active ingredient, and generally includes silica gel, polyacrylamide gel, dextran gel and the like. . The detection wavelength in the partition chromatography of the alcoholic extract of the grass plant seed may be 170 to 320 nm, preferably 190 to 280 nm.
イネ科植物種子(好ましくはコムギ属の植物)のアルコール抽出物(好ましくはエタノール抽出物)の精製に好適な分配クロマトグラフィーの例として、下記分配クロマトグラフィーA及びBが挙げられる。
・分配クロマトグラフィーA:担体としてシリカゲル及び移動相としてヘキサン−酢酸エチル混合溶媒を用いた中圧カラム法(中圧クロマトグラフィー)を用い、且つその分配クロマトグラフィーの実施中に、移動相を「ヘキサン−酢酸エチル混合溶媒においてヘキサンの含有割合が相対的に高いもの」から「ヘキサン−酢酸エチル混合溶媒においてヘキサンの含有割合が相対的に低いもの」へと変化させ(即ち、「ヘキサン大−少」へのグラジエントモードで用い)、且つ検出波長254nmでのピーク成分を分取する。
・分配クロマトグラフィーB:担体としてシリカゲル及び移動相としてメタノールを用いた高速液体クロマトグラフィー(HPLC)を用い、且つ検出波長215nmでのピーク成分を分取する。
Examples of partition chromatography suitable for purification of an alcohol extract (preferably an ethanol extract) of a grass seed (preferably a plant of the genus Wheat) include the following partition chromatography A and B.
Partition chromatography A: using a medium pressure column method (medium pressure chromatography) using silica gel as a carrier and a hexane-ethyl acetate mixed solvent as a mobile phase, and during the execution of the partition chromatography, -Changed from "relatively high hexane content in ethyl acetate mixed solvent" to "relatively low hexane content in hexane-ethyl acetate mixed solvent" And a peak component at a detection wavelength of 254 nm is fractionated.
Partition chromatography B: Using high performance liquid chromatography (HPLC) using silica gel as a carrier and methanol as a mobile phase, a peak component at a detection wavelength of 215 nm is fractionated.
本発明で用いる特定食品において、前記有効成分(前記一般式(I)で表されるアルキルレゾルシノール)の含有量は特に制限されず、特定食品は、前記有効成分のみから構成されていても良く、あるいは前記有効成分による作用効果を妨げない範囲で、前記有効成分以外の他の成分を含有していても良い。この他の成分としては、例えば、一般の食品に配合可能な各種の美容成分及び栄養成分、賦形剤、崩壊剤、結合剤、滑沢剤、界面活性剤、水溶性高分子、希釈剤、浸透圧調整剤、pH調整剤、乳化剤、防腐剤、緩衝剤、安定化剤、酸化防止剤、増粘剤、紫外線吸収剤、活性増強剤、着色剤、甘味料、矯味剤、矯臭剤、酸味料等が挙げられ、これらの1種を単独で又は2種以上を組み合わせて用いることができる。 In the specific food used in the present invention, the content of the active ingredient (alkylresorcinol represented by the general formula (I)) is not particularly limited, and the specific food may be composed only of the active ingredient, Or you may contain other components other than the said active ingredient in the range which does not prevent the effect by the said active ingredient. Other ingredients include, for example, various cosmetic and nutritional ingredients that can be incorporated into general foods, excipients, disintegrants, binders, lubricants, surfactants, water-soluble polymers, diluents, Osmotic pressure adjuster, pH adjuster, emulsifier, preservative, buffer, stabilizer, antioxidant, thickener, UV absorber, activity enhancer, colorant, sweetener, flavoring agent, flavoring agent, acidity A material etc. are mentioned, These 1 type can be used individually or in combination of 2 or more types.
本発明で用いる特定食品の形態は特に制限されず、固形、半固形又は液状であり得、錠剤形態、丸剤形態、カプセル形態、液剤形態、シロップ形態、粉末形態、顆粒形態等が挙げられる。本発明で用いる特定食品には飲料も含まれ、飲料の形態の特定食品としては、例えば、茶飲料、コーヒー飲料、乳飲料、果汁飲料、炭酸飲料、アルコール飲料、清涼飲料等が挙げられる。本発明で用いる特定食品の具体的な形態としては、パン類、麺類、ゼリー状食品や各種スナック類、焼き菓子、ケーキ類、チョコレート、ガム、飴、タブレット、カプセル、スープ類、乳製品、冷凍食品、インスタント食品、サプリメント、その他加工食品、調味料及びそれらの材料等が挙げられる。 The form of the specific food used in the present invention is not particularly limited, and may be solid, semi-solid, or liquid, and examples thereof include tablet form, pill form, capsule form, liquid form, syrup form, powder form, and granule form. Beverages are also included in the specific food used in the present invention, and examples of the specific food in the form of beverage include tea beverages, coffee beverages, milk beverages, fruit juice beverages, carbonated beverages, alcoholic beverages, and soft drinks. Specific forms of the specific food used in the present invention include breads, noodles, jelly-like foods and various snacks, baked goods, cakes, chocolate, gum, rice cake, tablets, capsules, soups, dairy products, frozen products. Examples include foods, instant foods, supplements, other processed foods, seasonings, and materials thereof.
本発明で用いる特定食品は、食品全般を包含し、いわゆる健康食品を含む一般食品の他、厚生労働省の保健機能食品制度に規定される特定保健用食品や栄養機能食品等の保健機能食品、サプリメント等を包含し、さらには動物に給餌される飼料も包含する。 The specific foods used in the present invention include all foods, in addition to general foods including so-called health foods, health functional foods such as foods for specific health and nutritional functional foods defined in the health functional food system of the Ministry of Health, Labor and Welfare, supplements Etc., and also feeds fed to animals.
本発明は、前述した特定食品の摂取方法に関するものであり、その主たる特徴の1つとして、特定食品を必要とする生体が睡眠から覚醒した後4時間以内、好ましくは3時間以内、さらに好ましくは2時間以内に摂取させる点が挙げられる。これにより、後述する実施例で実証されているように、特定食品による作用効果、特に抗肥満効果が最大限に高められ、肥満の予防又は改善が大いに促進され得る。 The present invention relates to the above-described method for ingesting a specific food, and one of its main features is that within 4 hours, preferably within 3 hours, more preferably after a living body that requires the specific food awakens from sleep. The point of ingesting within 2 hours is mentioned. Thereby, as demonstrated in the Example mentioned later, the effect by a specific foodstuff, especially an anti-obesity effect are maximized, and prevention or improvement of obesity can be promoted greatly.
本発明でいう「生体」には哺乳動物が含まれ、ヒトの他に、例えばイヌ、ネコ、マウス、ラット、ウサギ、ウシ、ウマ、サル等が含まれる。即ち、本発明の食品の摂取方法は、ヒトのみならず、ペット(愛玩動物)、家畜等に対しても適用可能であり、哺乳動物全般に対して非医療目的で実施し得る。 The “living body” as used in the present invention includes mammals, and includes humans, for example, dogs, cats, mice, rats, rabbits, cows, horses, monkeys, and the like. That is, the food intake method of the present invention can be applied not only to humans but also to pets (companion animals), livestock, and the like, and can be implemented for non-medical purposes on all mammals.
また、本発明でいう「睡眠」は、周囲の刺激に対する反応の低下を伴い、意識はないが容易に覚醒できる自然な状態であり、該状態が1日24時間の中に複数存在する場合は、それらのうちで該状態が最も長い持間継続したもののみが、本発明でいう「睡眠」に該当する。即ち、本発明でいう睡眠は、1日24時間の中で1回だけであり、また例えば、人が通常夜間にとる数時間に亘る睡眠(就寝)とは別に、昼間などにとる比較短時間に亘るいわゆる昼寝は、本発明でいう睡眠ではない。また、本発明の食品の摂取方法において、睡眠時間は特に制限されないが、好ましくは3時間以上、さらに好ましくは4〜10時間である。 In addition, “sleep” as used in the present invention is a natural state that is accompanied by a decrease in the response to surrounding stimuli and is not conscious but can be easily awakened, and when there are a plurality of such states within 24 hours a day Of these, only the one in which the state lasts for the longest time corresponds to “sleep” in the present invention. That is, the sleep in the present invention is only once in 24 hours a day, and for example, apart from sleep (sleeping) over several hours that a person usually takes at night, a comparatively short time taken in the daytime or the like. The so-called nap over the range is not sleep in the present invention. In the food intake method of the present invention, the sleep time is not particularly limited, but is preferably 3 hours or more, and more preferably 4 to 10 hours.
本発明の食品の摂取方法において、前述した特定食品は、睡眠から覚醒した後4時間以内に摂取すれば良く、覚醒後4時間以内であれば、1回で摂取しても良く、複数回に分けて摂取しても良い。 In the food intake method of the present invention, the specific food described above may be taken within 4 hours after waking up from sleep, and may be taken once within 4 hours after waking up. May be taken separately.
また、本発明の食品の摂取方法において、特定食品の摂取量は、摂取する生体の年齢若しくは体重又は特定食品の形態等によって適宜調整すれば良く、特に制限されないが、ヒトを対象とする場合は、前記有効成分の摂取量が1人1日当たり0.01〜10gとなるように調整することが好ましい。即ち、本発明の食品の摂取方法の好ましい実施態様として、睡眠から覚醒した後4時間以内に、1日当たり0.01〜10gの特定食品を、1回又は複数回に分けて、ヒトに摂取させる態様が挙げられる。 In addition, in the food intake method of the present invention, the intake of the specific food may be adjusted as appropriate according to the age or weight of the ingested living body or the form of the specific food, and is not particularly limited. The intake of the active ingredient is preferably adjusted to be 0.01 to 10 g per person per day. That is, as a preferred embodiment of the food intake method of the present invention, within 10 hours after waking up from sleep, 0.01 to 10 g of the specific food per day is divided into one or more times and allowed to be ingested by humans. An embodiment is mentioned.
また、ヒト以外の生体を対象とする場合において、特定食品の好ましい摂取量は下記の通りである。即ち、本発明の食品の摂取方法の好ましい実施態様として、睡眠から覚醒した後4時間以内に、下記の量の特定食品を、1回又は複数回に分けて、ヒト以外の生体に摂取させる態様が挙げられる。
・イヌの場合:1日当たり0.2mg〜20g
・ネコの場合:1日当たり1mg〜10g
・ハムスターの場合:1日当たり0.02mg〜40mg
・ウサギの場合:1日当たり0.4mg〜4g
In addition, when a living body other than a human is targeted, the preferred intake of the specific food is as follows. That is, as a preferred embodiment of the food intake method of the present invention, within 4 hours after waking up from sleep, the following specific amount of the specific food is divided into one time or a plurality of times and taken into a living body other than human beings. Is mentioned.
For dogs: 0.2 mg to 20 g per day
・ For cats: 1 mg to 10 g per day
For hamsters: 0.02 mg to 40 mg per day
-For rabbits: 0.4 mg to 4 g per day
また、本発明の食品の摂取方法の実施期間は特に制限されないが、一定期間連続的に実施することが好ましく、前述した特定食品による作用効果、特に抗肥満効果を十分に発現させる観点から、2週間以上、特に7週間以上連続して実施することが好ましい。 In addition, the period for carrying out the method for ingesting the food of the present invention is not particularly limited, but it is preferably carried out continuously for a certain period. From the viewpoint of sufficiently exhibiting the above-described effects of the specific food, particularly the anti-obesity effect, 2 It is preferable to carry out continuously for more than a week, particularly for more than 7 weeks.
本発明には、前述した特定食品と、特定食品についての説明書を含む商業用パッケージが包含される。この説明書には、特定食品が肥満の予防若しくは改善に使用し得るか又は使用すべきであること、及び、睡眠から覚醒した後4時間以内に特定食品を摂取することが記載されている。この商業用パッケージの形態は特に制限されず、例えば、特定食品を収容する包装容器に説明書が貼付されている形態、包装容器中に特定食品と共に説明書が同封されている形態、包装容器自体に説明書の記載内容が印刷されている形態(包装容器が説明書の形態)等が挙げられる。 The present invention includes a commercial package including the above-described specific food and instructions for the specific food. The instructions state that the specific food can or should be used for the prevention or amelioration of obesity and that the specific food is consumed within 4 hours after waking from sleep. The form of this commercial package is not particularly limited, for example, a form in which instructions are affixed to a packaging container containing specific food, a form in which instructions are enclosed with the specific food in the packaging container, or the packaging container itself The form in which the description content of the instruction is printed on (the packaging container is in the form of the instruction) and the like.
また本発明には、下記<1>の形態が含まれる。
<1>イネ科植物種子のアルコール抽出物の分配クロマトグラフィーのピーク成分を有効成分として含有する食品を、それを必要とする生体が睡眠から覚醒した後4時間以内に摂取させる、肥満の予防又は改善方法。
The present invention includes the following <1>.
<1> Prevention of obesity, wherein a food containing a peak component of partition chromatography of an alcohol extract of a grass plant seed as an active ingredient is ingested within 4 hours after a living body in need thereof awakes from sleep or How to improve.
以下、実施例を挙げて、本発明を更に詳細に説明するが、本発明は実施例により制限されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated further in detail, this invention is not restrict | limited by an Example.
下記<抽出精製法>により、前記一般式(I)で表されるアルキルレゾルシノールを含有する、小麦エタノール抽出物の分配クロマトグラフィーのピーク成分を得た。得られたピーク成分の組成は次の通り。
・1,3−ジヒドロキシ−5−n−ペンタデシルベンゼン(C15:0)1.2質量%。
・1,3−ジヒドロキシ−5−n−ヘプタデシルベンゼン(C17:0)10.9質量%。
・1,3−ジヒドロキシ−5−n−ノナデシルベンゼン(C19:0)33.9質量%。
・1,3−ジヒドロキシ−5−n−ヘンイコシルベンゼン(C21:0)46.4質量%。
・1,3−ジヒドロキシ−5−n−トリコシルベンゼン(C23:0)7.5質量%。
・1,3−ジヒドロキシ−5−n−ペンタコシルベンゼン(C25:0)0.1質量%。
By the following <extraction purification method>, the peak component of the partition chromatography of wheat ethanol extract containing the alkylresorcinol represented by the general formula (I) was obtained. The composition of the obtained peak component is as follows.
-1,3-dihydroxy-5-n-pentadecylbenzene (C15: 0) 1.2 mass%.
-1,3-dihydroxy-5-n-heptadecylbenzene (C17: 0) 10.9 mass%.
-1,3-dihydroxy-5-n-nonadecylbenzene (C19: 0) 33.9 mass%.
-1,3-dihydroxy-5-n-henicosylbenzene (C21: 0) 46.4 mass%.
-7.5 mass% of 1, 3- dihydroxy-5-n-tricosyl benzene (C23: 0).
-1,3-dihydroxy-5-n-pentacosylbenzene (C25: 0) 0.1 mass%.
<抽出精製法>
小麦ふすまに質量で5倍量のエタノールを添加して、600rpm、室温の条件で、16時間撹拌抽出した。抽出物を濾過して不要物を除きエタノール抽出液を回収した後、エタノールを留去し、小麦エタノール抽出物を得た。
次いで、この小麦エタノール抽出物を中圧クロマトグラフィーによって精製した。中圧クロマトグラフィー条件は下記の通りである。溶出開始後31〜36分に出現するピーク成分を回収して、溶媒留去し、小麦エタノール抽出物の分配クロマトグラフィーのピーク成分を得た。
(中圧クロマトグラフィーの条件)
・カラム:シリカゲル(インジェクトカラム3L、ハイフラッシュカラム5L、60Å、40μm、山善株式会社製)
・移動相:ヘキサン/酢酸エチル混合溶媒(体積比)=90/10にて9分、80/20にて15分、60/40にて16分
・検出波長:254nm
<Extraction purification method>
Ethanol in an amount of 5 times by mass was added to wheat bran, and the mixture was extracted by stirring for 16 hours under conditions of 600 rpm and room temperature. The extract was filtered to remove unnecessary substances and an ethanol extract was collected, and then ethanol was distilled off to obtain a wheat ethanol extract.
The wheat ethanol extract was then purified by medium pressure chromatography. Medium pressure chromatography conditions are as follows. The peak component appearing 31 to 36 minutes after the start of elution was collected, and the solvent was distilled off to obtain the peak component of partition chromatography of the wheat ethanol extract.
(Medium pressure chromatography conditions)
Column: silica gel (injection column 3 L, high flash column 5 L, 60 mm, 40 μm, manufactured by Yamazen Corporation)
・ Mobile phase: Hexane / ethyl acetate mixed solvent (volume ratio) = 9/10 at 90/10, 15 minutes at 80/20, 16 minutes at 60/40 ・ Detection wavelength: 254 nm
尚、前記<抽出精製法>における小麦エタノール抽出物の精製は、中圧クロマトグラフィーに代えて、HPLCによって行うこともできる。その場合、小麦エタノール抽出物にメタノールを添加して該エタノール抽出物の濃度が200ug/mlのメタノール添加液を調製し、該メタノール添加液を、孔径0.45μmのフィルターを通過させ、その通過分を、HPLCの試料とする。HPLCの条件は下記の通り。
(HPLCの条件)
・カラム:シリカゲル(ODS−80A、5μm、4.6×250mm、ジーエルサイエンス株式会社製)
・ガードカラム:ODS−80A、5μm、4.6×50mm、
・カラム温度:30℃
・移動相:メタノール100%
・検出波長:215nm
In addition, the purification of the wheat ethanol extract in the above <Extraction and purification method> can be performed by HPLC instead of medium pressure chromatography. In this case, methanol is added to the wheat ethanol extract to prepare a methanol additive solution having a concentration of 200 ug / ml, and the methanol additive solution is passed through a filter having a pore size of 0.45 μm. Are HPLC samples. HPLC conditions are as follows.
(HPLC conditions)
Column: silica gel (ODS-80A, 5 μm, 4.6 × 250 mm, manufactured by GL Sciences Inc.)
Guard column: ODS-80A, 5 μm, 4.6 × 50 mm,
-Column temperature: 30 ° C
-Mobile phase: 100% methanol
・ Detection wavelength: 215 nm
〔実施例1〕
高脂肪高ショ糖食(以下、HFHSDともいう)として、F2HFHSD(オリエンタル酵母工業株式会社製)を用い、HFHSDに前記の小麦エタノール抽出物の分配クロマトグラフィーのピーク成分を0.5質量%添加して、前述した特定食品に相当する飼料(以下、HFHSDARともいう)を調製した。
明期12時間、暗期12時間の明暗サイクル下(0:00点灯、12:00消灯)で馴化飼育したC57BL/6JJmsSlc系統のマウス(11週齢の雄性、日本エスエルシー株式会社)にHFHSD及びHFHSDARを8週間摂取させた。その試験期間中は1日2回の給餌を行い、そのうちの1回は、マウスが睡眠から覚醒した後4時間以内にHFHSDARを給餌してこれを摂取させ、他の1回は、マウスの就寝前4時間以内にHFHSDを給餌してこれを摂取させた。
[Example 1]
As a high fat high sucrose diet (hereinafter also referred to as HFHSD), F2HFHSD (manufactured by Oriental Yeast Co., Ltd.) is used, and 0.5% by mass of the peak component of the above-mentioned wheat ethanol extract partition chromatography is added to HFHSD. Thus, a feed corresponding to the above-mentioned specific food (hereinafter also referred to as HFHSDAR) was prepared.
C57BL / 6JJmsSlc strain mice (11-week-old male, Japan SLC, Inc.) bred under a light-dark cycle of 12 hours light period and 12 hours dark period (lit at 0:00, unlit at 12:00) HFHSDAR was ingested for 8 weeks. During the test period, the animals were fed twice a day, one of which was fed with HFHSDAR within 4 hours after the mice woke up from sleep, and the other one was the bedtime of the mice. HFHSD was fed within 4 hours before ingestion.
〔比較例1〕
マウスが睡眠から覚醒した後4時間以内に給餌する飼料をHFHSDとした以外は、実施例1と同様にした。即ち、前記試験期間中、マウスにHFHSDのみを摂取させた。
[Comparative Example 1]
The procedure was the same as Example 1 except that HFHSD was used as the feed fed within 4 hours after the mice woke up from sleep. That is, during the test period, the mice were ingested only with HFHSD.
〔比較例2〕
マウスが睡眠から覚醒した後4時間以内にHFHSDを給餌してこれを摂取させ、且つマウスの就寝前4時間以内にHFHSDARを給餌してこれを摂取させた以外は、実施例1と同様にした。
[Comparative Example 2]
Example 1 except that HFHSD was fed and consumed within 4 hours after the mice woke up from sleep, and HFHSDAR was fed and consumed within 4 hours before the mice went to sleep. .
(評価試験)
実施例及び比較例のマウスについて、前記試験期間中、1週間ごとにマウスの体重を測定し、試験前のマウスの体重に対する体重増加率(%)を算出した。その結果を図2に示す。また、前記試験期間の終了後、実施例及び比較例のマウスから採血し、血中レプチン濃度を測定した。レプチンの測定は、マウスレプチン測定キット(森永生化学研究所)を使用し、添付のプロトコールに従って実施した。その結果を図3に示す。レプチンは摂食抑制や脂肪分解効果をもたらすホルモンである。メタボリックシンドロームの生体はレプチンの制御機能が低下してしまい、レプチンが必要以上に血中に分泌されて血中レプチン濃度が高くなることが知られている。これをレプチン抵抗性という。メタボリックシンドロームの病態と血中レプチン濃度は相関があり、血中レプチン濃度が多い程メタボリックシンドローム病態が進行している傾向がある。尚、図3において、#は、実施例1と比較例1との間における有意差が、有意水準p<0.01で認められたことを示し、*は、実施例1と比較例2との間における有意差が、有意水準p<0.05で認められたことを示す。
(Evaluation test)
About the mouse | mouth of an Example and a comparative example, the weight of the mouse | mouth was measured every week during the said test period, and the weight increase rate (%) with respect to the body weight of the mouse | mouth before a test was computed. The result is shown in FIG. In addition, after completion of the test period, blood was collected from the mice of Examples and Comparative Examples, and blood leptin concentration was measured. Leptin was measured using a mouse leptin measurement kit (Morinaga Biochemical Laboratories) according to the attached protocol. The result is shown in FIG. Leptin is a hormone that suppresses eating and has a lipolytic effect. It is known that the metabolic syndrome living body has a reduced leptin control function, and leptin is secreted into the blood more than necessary, resulting in an increase in blood leptin concentration. This is called leptin resistance. There is a correlation between the pathological condition of metabolic syndrome and the blood leptin concentration, and the metabolic syndrome pathological condition tends to progress as the blood leptin concentration increases. In FIG. 3, # indicates that a significant difference between Example 1 and Comparative Example 1 was recognized at the significance level p <0.01, and * indicates that Example 1 and Comparative Example 2 It is shown that a significant difference was recognized at a significance level p <0.05.
実施例1は、比較例1及び2に比して、体重増加率(図2参照)及び血中レプチン濃度(図3参照)が有意に低く、高い抗肥満効果を有することがわかる。比較例2は、実施例1と同じく、小麦エタノール抽出物の分配クロマトグラフィーのピーク成分を定期的に摂取したにもかかわらず、実施例1に比して、抗肥満効果に劣る結果となった。
以上のことから、1)イネ科植物種子のアルコール抽出物の分配クロマトグラフィーのピーク成分に抗肥満効果があること、及び、2)その抗肥満効果はピーク成分(特定食品)を摂取するタイミングによって異なり、生体が睡眠から覚醒した後4時間以内に摂取することがより効果的であることがわかる。
It can be seen that Example 1 has a significantly lower body weight gain rate (see FIG. 2) and blood leptin concentration (see FIG. 3) than Comparative Examples 1 and 2, and has a high anti-obesity effect. As in Example 1, Comparative Example 2 resulted in inferior anti-obesity effect as compared to Example 1, despite regularly ingesting the peak component of the partition chromatography of the wheat ethanol extract. .
From the above, 1) the peak component of the partition chromatography of the alcoholic extract of the grass plant seed has an anti-obesity effect, and 2) the anti-obesity effect depends on the timing of ingesting the peak component (specific food) In contrast, it can be seen that it is more effective to ingest the living body within 4 hours after waking up from sleep.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015008329A JP2016132641A (en) | 2015-01-20 | 2015-01-20 | Food taking method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015008329A JP2016132641A (en) | 2015-01-20 | 2015-01-20 | Food taking method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019043631A Division JP2019104755A (en) | 2019-03-11 | 2019-03-11 | Method of feeding anti-obesity food and feed |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2016132641A true JP2016132641A (en) | 2016-07-25 |
Family
ID=56437342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015008329A Pending JP2016132641A (en) | 2015-01-20 | 2015-01-20 | Food taking method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2016132641A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019172579A (en) * | 2018-03-27 | 2019-10-10 | 国立研究開発法人産業技術総合研究所 | Sirtuin activity promoter |
JP2020186214A (en) * | 2019-05-16 | 2020-11-19 | 株式会社日清製粉グループ本社 | Slow wave activity promoter |
WO2020235546A1 (en) | 2019-05-22 | 2020-11-26 | 日東富士製粉株式会社 | Composition for improving liver function |
JP2021016363A (en) * | 2019-07-23 | 2021-02-15 | 株式会社日清製粉グループ本社 | Fat decomposition accelerator, food product containing the same, and processed food product for fat decomposition accelerator |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013040108A (en) * | 2011-08-11 | 2013-02-28 | Nisshin Seifun Group Inc | Anti-obesity medicine |
JP2014139166A (en) * | 2012-12-20 | 2014-07-31 | National Institute Of Advanced Industrial & Technology | Improvement agent for abnormal glucose tolerance |
-
2015
- 2015-01-20 JP JP2015008329A patent/JP2016132641A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013040108A (en) * | 2011-08-11 | 2013-02-28 | Nisshin Seifun Group Inc | Anti-obesity medicine |
JP2014139166A (en) * | 2012-12-20 | 2014-07-31 | National Institute Of Advanced Industrial & Technology | Improvement agent for abnormal glucose tolerance |
Non-Patent Citations (4)
Title |
---|
J.ARGIC.FOOD CHEM., vol. 40, JPN6018048457, 1992, pages 2127 - 2130, ISSN: 0003935416 * |
J.NUTRITION, vol. 145, no. 2, JPN6018010289, 26 November 2014 (2014-11-26), pages 199 - 206, ISSN: 0003935415 * |
LEBENSM.WISS.U.TECHNOL., vol. 25, no. 3, JPN6018048459, 1992, pages 248 - 252, ISSN: 0003935417 * |
PHARMACOGNOSY MAGAZINE, vol. 9, no. 36, JPN6018010287, 2013, pages 309 - 314, ISSN: 0003935414 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019172579A (en) * | 2018-03-27 | 2019-10-10 | 国立研究開発法人産業技術総合研究所 | Sirtuin activity promoter |
JP2020186214A (en) * | 2019-05-16 | 2020-11-19 | 株式会社日清製粉グループ本社 | Slow wave activity promoter |
JP7260113B2 (en) | 2019-05-16 | 2023-04-18 | 株式会社日清製粉グループ本社 | Slow-wave activity promoter |
WO2020235546A1 (en) | 2019-05-22 | 2020-11-26 | 日東富士製粉株式会社 | Composition for improving liver function |
JP2021016363A (en) * | 2019-07-23 | 2021-02-15 | 株式会社日清製粉グループ本社 | Fat decomposition accelerator, food product containing the same, and processed food product for fat decomposition accelerator |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6745250B2 (en) | Moringa extract | |
US8828955B2 (en) | Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed | |
JP6353034B2 (en) | Diabetes preventive or ameliorating agent | |
JP6241000B2 (en) | Glucose tolerance improving agent | |
JP2016132641A (en) | Food taking method | |
JP2023157951A (en) | Composition for improving liver function | |
JP5403942B2 (en) | Glutathione production promoter and preventive / therapeutic agent for diseases caused by glutathione deficiency | |
JP7149548B2 (en) | Composition for prevention, improvement or treatment of muscle diseases, or for improving muscle function, containing an extract of damselfly | |
JP2011157343A (en) | Peroral anti-aging agent | |
JP2011207776A (en) | Adiponectin production-promoting agent | |
WO2015193962A1 (en) | Agent for improving glucose tolerance disorder | |
JP6161438B2 (en) | Fat accumulation inhibitor and / or fat accumulation reducing agent | |
JP6460402B2 (en) | Pharmaceutical composition or food composition for promoting cholesterol excretion | |
JP2019104755A (en) | Method of feeding anti-obesity food and feed | |
JP2017178805A (en) | Lps production inhibiting agent, and food composition for inhibiting lps production | |
JP6144564B2 (en) | Inflammation prevention agent | |
JP7445689B2 (en) | lipolysis accelerator | |
JP7126731B1 (en) | AMPK activator, motor function improver, muscle endurance improver and muscle atrophy inhibitor | |
JP7239135B2 (en) | α-Glucosidase activity inhibitor and blood sugar elevation inhibitor | |
JP7253764B2 (en) | athletic performance enhancer | |
JP2023038107A (en) | Lipid synthesis inhibitor, and food and drink, processed food for inhibited lipid synthesis and expression inhibitor comprising the same | |
JP2007176837A (en) | Composition for slimming | |
JP2021016363A (en) | Fat decomposition accelerator, food product containing the same, and processed food product for fat decomposition accelerator | |
JP4714438B2 (en) | Anti-fatigue agent and food and drink containing the same | |
JP2023069459A (en) | Cyclic AMP phosphodiesterase activity inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170621 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20170621 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180327 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180518 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180706 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20181211 |